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Abstract
Background: Reuterin produced from glycerol by Lactobacillus reuteri, a normal inhabitant of the
human intestine, is a broad-spectrum antimicrobial agent. It has been postulated that reuterin could
play a role in the probiotic effects of Lb. reuteri. Reuterin is active toward enteropathogens, yeasts,
fungi, protozoa and viruses, but its effect on commensal intestinal bacteria is unknown. Moreover
reuterin's mode of action has not yet been elucidated. Glutathione, a powerful antioxidant, which
also plays a key role in detoxifying reactive aldehydes, protects certain bacteria from oxidative
stress, and could also be implicated in resistance to reuterin.
The aim of this work was to test the activity of reuterin against a representative panel of intestinal
bacteria and to study a possible correlation between intracellular low molecular weight thiols
(LMW-SH) such as glutathione, hydrogen peroxide and/or reuterin sensitivity. Reuterin was
produced by Lb. reuteri SD2112 in pure glycerol solution, purified and used to test the minimal
inhibitory (MIC) and minimal bactericidal concentrations (MBC). Hydrogen peroxide sensitivity and
intracellular LMW-SH concentration were also analysed.
Results: Our data showed that most tested intestinal bacteria showed MIC below that for a
sensitive indicator Escherichia coli (7.5–15 mM). Lactobacilli and Clostridium clostridioforme were
more resistant with MIC ranging from 15 to 50 mM. No correlation between bacterial intracellular
concentrations of LMW-SH, including glutathione, and reuterin or hydrogen peroxide sensitivities
were found.
Conclusion: Our data showed that intestinal bacteria were very sensitive to reuterin and that
their intracellular concentration of LMW-SH was not directly linked to their capacity to resist
reuterin or hydrogen peroxide. This suggests that detoxification by LMW-SH such as glutathione
is not a general mechanism and that other mechanisms are probably involved in bacterial tolerance
to reuterin and hydrogene peroxide.
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Lactobacillus reuteri is a heterofermentative lactic acid bac-
teria that belongs to the authochtonous microbiota of
humans and animals [1]. Animal studies have shown that
certain Lb. reuteri strains used as probiotics can provide
protection against detrimental effects of certain microbio-
logical, chemical and physical stressors; lower cholesterol;
modulate immune responses; and improve the develop-
ment of ileal tissue [2-4]. Lb. reuteri SD2112 (ATCC
55730) has been shown to reduce the incidence and sever-
ity of diarrhoea of different origins in children and adults
[5-7], and to survive the passage through the stomach and
upper intestine and transiently colonize the human gas-
trointestinal tract [6]. Indeed, this strain has been used for
more than ten years as probiotic and/or starter culture in
food and health care products [4].
In the presence of glycerol Lb. reuteri can synthesize 3-
hydroxypropionaldehyde (3-HPA). 3-HPA is excreted into
the medium where it forms together with the hydrate and
the dimer (reuterin), a dynamic multi-component equi-
librium (HPA, HPA system: named reuterin in most pub-
lications) [4]. Reuterin is a potent antimicrobial agent
active against Gram positive and Gram negative bacteria,
as well as yeasts, moulds and protozoa [8]. Reuterin is
synthesized in vitro under pH, temperature and anaerobic
conditions similar to those of the gastrointestinal tract [9].
In vivo, active reuterin synthesis could occur in the colon
via Lb. reuteri metabolism, if sufficient amounts of glyc-
erol become available as a product of luminal microbial
fermentations, digestion of luminal fats, sloughed mucus
and desquamated epithelial cells, and intestinal clearing
of endogenous plasma glycerol [2]. To our knowledge,
there are presently no data concerning the amount of glyc-
erol available for bacterial conversion to reuterin in the
human intestine. 
Reuterin is water soluble, effective in a wide range of pH,
resistant to proteolytic and lipolytic enzymes and has
been therefore studied as a food preservative or auxiliary
therapeutic agent [4,8,10]. Reuterin is also believed to
play a role in the probiotic effects of Lb. reuteri SD2112,
but its mode of action on microbial growth has not been
elucidated due to the high complexity of the HPA-system
chemistry [4]. It has been postulated that reuterin might
inhibit the activity of bacterial ribonucleotide reductase,
an enzyme catalyzing the first step in DNA synthesis, by
competition (HPA-dimer) with ribonucleotides for bind-
ing sites or by reaction (3-HPA) with unstable sulfhydryl
groups of ribonucleotide reductase or with thioredoxin
which is required for enzymatic activity [11]. The inhibi-
tion of the conversion of ribonucleotides to deoxyribonu-
cleotides would explain the broad-spectrum activity of
reuterin [11]. It has also been suggested that the mecha-
nism of action of reuterin might be directed towards sulf-
hydryl enzymes, and that the tolerance of bacteria to
reuterin might be associated with intracellular levels of
LMW-SH such as glutathione (unpublishd data).
Reduced glutathione (GSH), is a cysteine-containing
tripeptide, mostly found in Gram negative bacteria such
as purple and cyanobacteria. The highest GSH concentra-
tions are observed in aerobes or facultative anaerobes,
whereas strict anaerobes are generally deprived of GSH
but possess other soluble thiol compounds [12]. How-
ever, some faculative anaerobic Gram positive bacteria
(eg. Lactococcus lactis subsp. lactis, Streptococcus agalactiae
ATCC 12927 or Enterococcus faecalis ATCC 29212) can
synthesize significant amount of GSH, whereas others
(e.g. Lactococcus lactis subsp. cremoris Z8 or Streptococcus
mutans ATCC 33402) can import GSH from the growth
medium, but this faculty is strain dependent [13,14]. GSH
plays important functions in bacteria including control of
redox potential, protection against oxidative stress,
detoxification of endogenously and exogenously derived
toxins, protein folding and storage and transport of
organic sulfur [15]. This potent antioxidant is also
believed to play a key role in detoxification of reactive
aldehydes, such as acrolein and protects cells from oxida-
tive damage such as produced by H2O2 [16]. Recently, glu-
tathione reductase has been shown to contribute to
Lactobacillus sanfranciscensis oxygen tolerance [17]. Vari-
ous studies have reported the MIC of reuterin against
pathogens and lactic acid bacteria [9,11,18]. However, the
activity of pure reuterin against intestinal bacteria has
never been reported, even though this data is important
for understanding the probiotic effects of Lb. reuteri in vivo
when administered to humans and animals. The aim of
this study was therefore to determine the in vitro antibac-
terial activity of pure reuterin on a representative panel of
human intestinal bacteria. The intracellular concentration
of LMW-SH and the sensitivity of intestinal bacteria to
hydrogen peroxide were also recorded to tentatively corre-
late reuterin sensitivity to intracellular LMW-SH such as
GSH and oxygen tolerance.
Results
Production and purification of reuterin
Approximately 170 mM reuterin was produced by Lb. reu-
teri SD2112 from 200 mM glycerol. After purification of
140 ml of this solution, about 1 g of pure reuterin was
recovered, corresponding to a yield of 57 %. A high purity
of reuterin, free from contaminants such as glycerol and
1,3 propanediol, was obtained after the purification proc-
ess, as shown by HPLC analysis (Figure 1).
Antimicrobial activity
The MIC and MBC of the tested bacteria are presented in
Table 1. As expected, Lb. reuteri was the most resistant spe-
cies, with MIC and MBC ranges for both tested strains ofPage 2 of 9
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other lactobacilli (MIC range 15–40 mM; MBC range
15–80 mM). The MIC and MBC for the sensitive strain
Escherichia coli were in the range from 7 to 15 mM and
from 15 to 30 mM, respectively.
Among the 19 (non lactobacilli) tested species, 15
showed MIC values below that measured for the indicator
E. coli strain with MIC equal or below 7.5 mM. The most
sensitive strains to reuterin were Bacteroides vulgatus and
Clostridium difficile (MIC < 1.9 mM), followed by Bacter-
oides thetaiotaomicron, Eubacterium eligens, Bifidobacterium
longum var infantis, Eubacterium biforme, Bifidobacterium
longum and Bifidobacterium catenulatum (MIC range from
1.9 to 3.8 mM). The four most resistant non lactobacilli
species were Clostridium clostridioforme (MIC range 15–30
mM; MBC 15–30 mM) followed by Ruminococcus produc-
tus, Bifidobacterium breve and Listeria innocua (MIC range
7.5–15 mM and MBC range 3.8–15 mM).
Intracellular LMW-SH concentration including GSH
Intracellular concentrations of LMW-SH in tested bacteria
are reported in Table 1. LMW-SH were detected in all bac-
teria and was in the range from 1.3 to 3.1 μmol/1012 col-
ony forming unit [cfu]) for many bacteria. The highest
concentrations were found in Cl. difficile (43 μmol/
1012cfu) followed by Collinsella aerofaciens, Lactobacillus
salivarius, Lactobacillus acidophilus and Streptococcus salivar-
ius (ranging from 22 to 10 μmol/1012 cfu). E. coli, Bacter-
oides fragilis, Lb. reuteri (DSM 20016 and SD 2112),L.
innocua, B. longum var infantis and Enterococcus faecium
showed intermediate values ranging from 8 to 5 μmol/
1012 cfu).
Sensitivity to H2O2
The sensitivity of several intestinal bacteria to H2O2 is
shown in Table 2. For all tested bacteria, except for E. fae-
cium, exposure to 10, 20 and 30 g l-1 H2O2 caused a
decrease in viable cell counts compared to the control
medium without H2O2. Among the 25 tested, the 4 most
resistant species were E. faecium, Lb. acidophilus, Lb. reuteri
(DSM 20016) and S. salivarius with survival rates to 30 g l-
1 H2O2 ranging from 75.6 to 0.06%. The second group, B.
longum var infantis and Lactobacillus fermentum survived to
20 g l-1 H2O2(at 0.18 and 0.02 % respectively), whereas a
third group with four bifidobacteria and three lactobacilli
species showed survival rates to 10 g l-1 H2O2 ranging from
0.07 to 24.9 %. The most sensitive group with complete
growth inhibition with 10 g l-1 of H2O2included 9 species
belonging to known strict anaerobe genera from the
human gut (Bacteroides spp., Clostridium spp., C. aerofa-
ciens, E. biforme, R. productus and one bifidobacteria
among 6 tested). Surprisingly, Listeria spp. and E. coli, clas-
sified as facultative anaerobes, were also completely
inhibited with 10 g l-1 H2O2.
Discussion
In this study, the MIC and MBC of pure reuterin for differ-
ent intestinal bacteria were determined using a serial dilu-
tion microtiter plate assay. With the exception of
Dobrogosz et al. [19], who express the inhibitory activity
of reuterin with arbitrary units defined, after analysis with
14C-labeled glycerol, as 1 U equal 8 μg reuterin/ml, most
of the authors have used poorly defined arbitrary units to
express the inhibitory concentration of reuterin [10,20].
Therefore, a direct comparison of published data for anti-
microbial activities of reuterin against different bacteria is
difficult. Another problem of these studies is that the
molar concentration of reuterin was calculated using the
molecular mass of the dimer form [9,11,21,22], although
reuterin occurs in its monomeric form at the low concen-
trations used [4]. Moreover arbitrary units are changed by
many experimental factors as shown for bacteriocins, such
as variation of sensitivity among indicator strains of the
same species, medium and incubation conditions for the
HPLC chromatogramsFigure 1
HPLC chromatograms. a) supernatant before purifica-
tion; b) reuterin after purification on a silica gel 60 chroma-
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pounds in tested preparations [23,24]. For data compari-
son, test conditions must be standardized and MIC data
expressed in μg ml-1 or mM. In this study the molar con-
centration of reuterin was determined by a method origi-
nally developed for acrolein quantification, using the
acid-catalyzed formation of a colored complex between
acrolein/HPA and tryptophan [25], which has been
adopted by several other authors to correctly quantify reu-
terin [4,26-28]. Furthermore, all bacteria were tested
under controlled test conditions and the same medium
for the activity test.
Our data showed that reuterin is an effective inhibitor for
most tested intestinal bacteria, with the exception of lacto-
bacilli. Among the 20 species non belonging to the Lacto-
bacillus genus, 14 were inhibited and/or killed by reuterin
concentrations equal or below 3.8 mM. They exhibited
higher sensitivity than E. coli, the usual sensitive indicator
used to test reuterin [4]. Dobrogosz et al. [11] and Chung
et al. [9] reported, using a two-fold dilution test, MIC for
E. coli K12 of 4–5 U/ml (0.9–1.1 mM, after recalculation
based on 3-HPA monomer and 1 U = 8 μg reuterin/ml),
32 U/ml (6.9 mM) for Lb. reuteri and ranging from 4 to 42
U/ml (0.9–9.1 mM) for different lactobacilli. Our data
show the same trends; MIC values for lactobacilli were at
least 2 times higher than for E. coli (Table 1). However,
under our test conditions, MIC measured for lactobacilli
were approximately 10 times higher than reported in pre-
vious studies. Dobrogosz et al. [11] found that Listeria
monocytogenes showed a similar low sensitivity to reuterin
as for lactobacilli, with MIC of 4–42 U/ml (0.9–9.1 mM),
which was different from our data for L. ivanovii and L.
innocua, which were much more sensitive to reuterin than
lactobacilli. These differences for MIC measured in differ-
ent studies can be due to various factors of the arbitrary
activity tests, including pH, culture media, incubation
temperature, concentration and physiological state of the
tested bacteria which affect both the growth [23] of the
tested strains and the activity of reuterin [27]. As well, a
strict criteria for MIC calculation (lowest reuterin concen-
tration resulting in complete inhibition of the tested
Table 1: Reuterin activity and LMW-SH concentration in intestinal bacteria
Organisms Strainsa MICb[mM] MBCb [mM] LMW-SHc [μmol/1012 cells]
Escherichia coli DSM 5698 7.5–15.0 15.0–30.0 7.9 ± 1.3
Bacteroides vulgatus DSM 1447 < 1.9 1.9–3.8 1.6 ± 0.4
Bacteroides thetaiotaomicron DSM 2079 1.9–3.8 1.9–3.8 -d
Bacteroides fragilis LMG 10263 3.8–7.5 3.8–7.5 7.3 ± 1.7
Bifidobacterium catenulatum LMG 11043 1.9–3.8 7.5–15.0 1.8 ± 0.9
Bifidobacterium longum DSM 20219 1.9–3.8 3.8–7.5 1.5 ± 0.5
Bifidobacterium longum infantis DSM 20088 1.9–3.8 1.9–3.8 5.2 ± 0.6
Bifidobacterium adolescentis DSM 20083 3.8–7.5 -d 1.3 ± 0.1
Bifidobacterium bifidum DSM 20456 3.8–7.5 7.5–15.0 2.4 ± 0.5
Bifidobacterium breve DSM 20213 7.5–15 7.5–15.0 2.0 ± 0.1
Lactobacillus acidophilus ATCC 4356 15.0–40.0 15.0–40.0 10.7 ± 0.3
Lactobacillus casei ATCC 334 15.0–40.0 40.0–80.0 2.0 ± 0.3
Lactobacillus fermentum ETH-Z 15.0–40.0 15.0–40.0 2.9 ± 1.2
Lactobacillus salivarius ETH-Z 15.0–40.0 40.0–80.0 22.2 ± 5.0
Lactobacillus reuteri DSM 20016 30.0–50.0 60–120. 6.5 ± 0.8
Lactobacillus reuteri SD 2112 30.0–50.0 60–120 6.1 ± 1.4
Eubacterium biforme DSM 3989 1.9–3.8 3.8–7.5 3.0 ± 0.7
Eubacterium eligens DSM 3376 1.9–3.8 1.9–3.8 -d
Colinsella aerofaciens DSM 3979 3.8–7.5 7.5–15.0 21.9 ± 4.3
Enterococcus faecium DSM 20477 3.8–7.5 30.0–50.0 4.8 ± 1.3
Streptococcus salivarius DSM 20560 3.8–7.5 15.0–30.0 9.6 ± 1.1
Clostridium difficile ETH-Z < 1.9 3.8–7.5 43.0 ± 3.8
Clostridium clostridioforme DSM 933 15.0–30.0 15.0–30.0 3.1 ± 0.8
Ruminococcus productus DSM 2950 7.5–15.0 3.8–7.5 2.5 ± 0.5
Listeria innocua HPB 13 7.5–15.0 7.5–15.0 5.5 ± 1.4
Listeria ivanovii HPB 28 3.8–7.5 7.5–15.0 1.5 ± 0.6
aDSM: Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany ATCC: American Type Culture Collection, Rockville, 
Maryland, USA HPB: Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, Canada ETH-Z:Culture Collection of the Food 
Biotechnology Laboratory, ETH Zürich, Switzerland LMG: Belgian Co-Ordinated Collections of Micro-Organisms, Gent, Belgium SD2112 = 
BioGaia, Stockholm, Sweden
bMIC and MBC data are expressed as the range obtained from at least three independent repetitions for each species
cLMW-SH concentrations are expressed as mean ± SD of at least three independent repetitions
dNot determinedPage 4 of 9
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HPA is highly reactive due to its β-hydroxy moiety and
therefore the molecule spontaneously reacts with availa-
ble amino- and sulfhydryl-functional groups present in
compounds of the growth medium and bacteria [4].
According to Lüthi-Peng et al. [27], only 30 % of reuterin
remains free after 24 h of incubation at 37°C in a complex
medium. The lactobacilli were also tested in the LAMVAB
growth medium [29], which is used as selective medium
to enumerate lactobacilli in fecal samples, at pH 5.0. With
this medium MIC were 2–5 times lower than the MIC
obtained with supplemented BHI (data not shown). This
result clearly shows that the comparison of data from dif-
ferent studies on reuterin activity is difficult, but compar-
ison within one study is much more valid. This limitation
should also be taken into account when sensitivity data to
antimicrobial compounds such as reuterin obtained with
in vitro tests, are extrapolated to other in vitro systems or in
vivo conditions such as in the gastrointestinal tract.
To tentatively explain the different behavior of intestinal
bacteria toward reuterin activity, we analyzed their intrac-
ellular concentration of LMW-SH including GSH, which
has been shown to be involved in aldehyde detoxification
mechanisms [30]. With this intention, we used the Ell-
mann's reagent that specifically reacts with thiol groups.
To make the distinction between LMW-SH, and thiol
groups of proteins, the concentration of intracellular
LMW-SH was determined in the cell-free supernatant of
bacterial crude extracts after protein elimination by pre-
cipitation with sulfosalicylcylic acid. Although, all LMW-
SH and not only GSH were measured in the present study,
this test gives a good estimation of GSH concentration
because other LMW-SH occur only in low concentration
[31]. LMW-SH were present in all tested bacteria. The
highest intracellular concentrations (> 20 μmol/1012
cells) were measured in two Gram positive strict anaerobic
species (C. aerofaciens and Cl. difficile) and one facultative
anaerobic bacteria (Lb. salivarius). Although glutathione
appears to be mostly present in cyanobacteria and purple
bacteria [12], high intracellular glutathione concentra-
tions have already been measured in Gram positive Clos-
driales, including strict anaerobes such as Clostridium
perfringens [32] and Lactobacillus spp. [33,34] and Bifido-
bacterium spp. [35]. It is usually suggested that Gram pos-
itive organisms do not produce GSH but accumulate it
from the growth medium. However, other evidences indi-
cate that some Gram positive bacteria (e.g. Enterococcus
faecalis ATCC 29212 or Streptococcus agalactiae ATCC
12927) can synthetize GSH [13]. Moreover, Fernandes
Table 2: Bacterial survival rates (%) after exposure to different hydrogen peroxide concentrations








Escherichia coli DSM 5698 100 ng1 ng ng
Bacteroides vulgatus DSM 1447 100 ng ng ng
Bacteroides thetaiotaomicron DSM 2079 100 ng ng ng
Bacteroides fragilis LMG 10263 100 ng ng ng
Bifidobacterium catenulatum LMG 11043 100 0.56a ng ng
Bifidobacterium longum DSM 20219 100 0.47a ng ng
Bifidobacterium longum infantis DSM 20088 100 5.90b 0.18abc ng
Bifidobacterium adolescentis DSM 20083 100 0.67a ng ng
Bifidobacterium bifidum DSM 20456 100 ng ng ng
Bifidobacterium breve DSM 20213 100 24.9bc ng ng
Lactobacillus acidophilus ATCC 4356 100 25.5bc 3.83bd 3.88a
Lactobacillus casei ATCC 334 100 0.07a ng ng
Lactobacillus fermentum ETH-Z 100 0.72a 0.02c ng
Lactobacillus salivarius ETH-Z 100 0.71a ng ng
Lactobacillus reuteri DSM 20016 100 0.35a 0.06c 0.09b
Lactobacillus reuteri SD 2112 100 0.16a ng ng
Eubacterium biforme DSM 3989 100 ng ng ng
Colinsella aerofaciens DSM 3979 100 ng ng ng
Enterococcus faecium DSM 20477 100 66.1c 48.4d 75.6c
Streptococcus salivarius DSM 20560 100 0.57a 0.20abc 0.06b
Clostridium difficile ETH-Z 100 ng ng ng
Clostridium clostridioforme DSM 933 100 ng ng ng
Ruminococcus productus DSM 2950 100 ng ng ng
Listeria innocua HPB 13 100 ng ng ng
Listeria ivanovii HPB 28 100 ng ng ng
1No growth
Different letters in a line indicate significant differences with the Tukey's test (P < 0.05)Page 5 of 9
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lactic acid bacteria varied widely between organisms and
were very dependent on strains tested as well as growth
conditions, including growth medium composition (pres-
ence or absence of GSH or precusors) and aeration, as well
as bacterial growth phase. Very few data are reported on
the capacity of intestinal bacteria to synthesize or harvest
GSH from the growth medium. It has been shown that
some probiotic lactobacilli strains can produce and even
release high amount of GSH [36]. In our study, the growth
medium was deprived of cystein, which is a major precur-
sor for GSH synthesis. However, GSH from yeast extract
was likely available for bacterial uptake in the growth
medium [12]. We recently observed that external addition
of GSH could conteract the toxicity of reuterin (3-HPA)
toward E. coli K12, which suggests a correlation between
induced toxicity of 3-HPA on E. coli K12 and depletion of
GSH (unpublished data). However, in this study, the lack
of correlation between intracellular GSH concentration
and reuterin sensitivity suggests that other detoxification
mechanisms prevent 3-HPA toxicity, such as 1,3-propane-
diol-dehydrogenase, which converts 3-HPA to the unreac-
tive 1,3-propanediol. No inhibitory activity of 1,3-
propanediol against intestinal bacteria is known until
now.
GSH is considered to play a key role in protecting cells
against oxidative stress. It is usually the most abundant
intracellular, low-molecular-weight thiol in E. coli [32]
and might contribute to protect E. coli cells [30] as well as
Gram positive bacteria [34] from the lethal effects of oxi-
dative damage. It is known that GSH can reduce hydrogen
peroxide in exchange for oxidation of GSH to glutathione
disulfide (GSSG) [30]. The tolerance of intestinal bacteria
to hydrogen peroxide was then determined to assess a
possible correlation between their sensitivity to reuterin
and oxygen detoxification. Oxygen toxicity is considered
to result from the effects of activated compounds includ-
ing superoxide, hydrogen peroxide and hydroxyl radicals
[37]. Facultative anaerobic bacteria decompose and
detoxify these activated oxygen metabolites enzymatically
with superoxide dismutase and catalase [37]. Most of the
intestinal bacteria, classified as strict anaerobic organisms,
are devoid of these enzymes and therefore their growth
can be inhibited when H2O2 is present [37]. Indeed, the
most oxygen sensitive species tested, which belongs to the
orders Bacteroidales (Bacteroides spp.) and Clostridiales
(Clostridium spp., Ruminococcus sp., Eubacterium spp. and
Collinsella sp.) were completely inhibited with 10 g l-1
hydrogen peroxide. Five bifidobacteria among the six
tested, were not inhibited by 10 g l-1 hydrogen peroxide
although they are classified as a strict anaerobic bacteria.
Using the same technique, Shimamura et al. [37] reported
variations in H2O2 sensitivity of Bifidobacterium spp., and
found similar results with B. infantis being the least sensi-
tive to H2O2, followed by B. breve, B. adolescentis and B.
longum. The facultative anaerobic bacteria tested were
found to largely differ in their sensitivities to hydrogen
peroxide. Among lactobacilli, Lb. acidophilus and Lb. reu-
teri DSM 20016 were the most tolerant.Lb. acidophilus and
Bifidobacterium spp. have NADH oxidase and NADH per-
oxidase to scavenge hydrogen peroxide and prevent cell
death in the presence of oxygen [37,38]. Moreover, it is
known that some Lb. acidophilus strains produce hydrogen
peroxide and peroxidase [39]. In addition, certain lactoba-
cilli produce superoxide dismutase [40] and a non-heme
pseudocatalase [41].
Surprinsigly, E. coli and Listeria spp. also classified as fac-
ultative anaerobes and which possess a catalase were
inhibited by 10 g l-1 hydrogen peroxide. But it has also
been shown that the high H2O2 sensitivity of E. coli can be
related to DNA damage caused by hydrogen peroxide
[42]. In this study, we did not establish any correlation
between bacterial hydrogen peroxide sensitivity and intra-
cellular LMW-SH concentration or reuterin sensitivity.
However, the wide range of organisms tested an the mul-
tiplicity of oxygen detoxification mechanisms as well as
the wide functions of LMW-SH and GSH in microorgan-
isms [15] suggest that strain specific mechanisms are
likely to be involved rather than a general mechanism
applicable to all bacteria.
Conclusion
This study reports for the first time the antimicrobial activ-
ity of reuterin on various intestinal bacteria. Large differ-
ences among species were observed. With the exception of
Lactobacillus strains which were more resistant, most intes-
tinal bacteria were inhibited by reuterin concentration
below 7.5 mM. Moreover, the MBC (7.5–15 mM)
recorded for the two Listeria spp. tested were higher than
for the main intestinal commensals. The most sensitive
species were inhibited by reuterin concentration around 2
mM, which suggests that low concentration of reuterin
production in situ (if sufficient amount are present either
via in situ production or ingested as encapulated form
with a probiotioc bacteria) seems to be sufficient to alter
the intestinal bacterial growth. However caution should
be applied when extrapolating these results obtained with
in vitro activity tests to specific in vivo conditions, where
other important factors such as nutrient competition and
antagonistic and/or synergistic relationships between the
intestinal microbiota can largely influence the inhibition
effects of antimicrobials such as reuterin. Complementary
experiments are therefore needed in more complex in vitro
systems, such as in vitro intestinal fermentation models, as
in vivo experimentation is very difficult. No correlation
was found between bacterial sensivity to reuterin and
intracellular LMW-SH and/or hydrogen peroxide sensitiv-
ity. Our data suggest that protection via LMW-SH such asPage 6 of 9
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If not otherwise stated, all chemicals were obtained from
Fluka, Buchs, Switzerland.
Bacterial strains, media and growth conditions
The bacteria used in this study are shown in Table 1. All
strains were kept frozen at -80°C in 25 % (v/v) glycerol
supplemented with L-cysteine (0.05 %). Before use, intes-
tinal bacteria were sub-cultured at least twice at 24 h inter-
vals in brain heart infusion (BHI, Biolife, Milano, Italy)
medium supplemented with yeast extract (5 g/l), K2HPO4
(1 g/l), glucose (8 g/l), Tween 80 (1 ml/l), hemin (0.005
g/l), vitamin K1 (0.002 g/l) and titanium citrate (0.6 mM)
as reduction agent, at 37°C (pH 6.6) under N2and CO2
gas atmosphere (1.5 bar, 80:20 [v/v]). Tested bacteria
were incubated between 14 and 18 h at 37°C. Lb. reuteri
SD2112 (ATCC 55730) that was used to produce reuterin
[27] was grown at 37°C in MRS broth [43] from Difco
Laboratories (Milan, Italy).
Reuterin production
Reuterin was produced as previously described by Vollen-
weider et al. [44]. Briefly, Lb. reuteri was inoculated at 1%
(v/v) in 10 ml MRS broth, incubated overnight at 37°C
and added to 50 ml MRS medium which was then incu-
bated for 3 h at 37°C. This culture was added to 1 L of
MRS medium supplemented with 20 mM glycerol and
incubated overnight. The cells were then harvested by cen-
trifugation at 1500 × g for 10 min at 20°C, washed with
potassium phosphate buffer (0.1 M, pH 7.0), resuspended
in 300-ml sterile aqueous solution of glycerol (200 mM)
and incubated for 2 h at 37°C. The cells were removed by
centrifugation (8000 × g, 10 min), and 140 ml of the
supernatant was filter-sterilized (FP/30/0.2 CA-S; Sch-
leicher & Schuell GmbH, Einbeck, Germany) and lyophi-
lized. Reuterin was purified on a silica gel 60
chromatography column (Merck, Darmstadt, Germany),
with acetone:ethyl acetate (2:1) as eluent. The 3-HPA
solution was diluted with distilled water to obtain a 10 M
solution, which was stable for at least 6 months at 4°C.
The concentration and purity of 3-HPA was verified by
colorimetric method and HPLC analysis as described
below.
3-HPA quantification
The concentration of reuterin in the tested solution was
determined with the assay for 3-HPA content, based on
the colorimetric method of Circle et al. [25], using acro-
lein for calibration as described by Vollenweider et al.
[44]. The solution of 3-HPA was also analyzed by HPLC
(Hitachi LaChrome, Merck, Dietikon, Switzerland) on an
Aminex HPX-87H column (300 × 7.8 mm, Bio Rad, Rein-
ach, Switzerland) with 10 mM H2SO4 as eluent and a flow
rate of 0.6 ml min-1 [45].
Antimicrobial activity
The minimal inhibitory (MIC) and bactericidal (MBC)
concentrations of 3-HPA were determined using a micro-
titer assay based on the method described by Mota-Meira
et al. [46] with modification. All manipulations were done
in an anaerobic chamber under an atmosphere of nitro-
gen containing 5 % (v/v) hydrogen. Briefly, bacteria were
grown anaerobically in supplemented BHI at 37°C for 15
to 18 h. The optical density (OD590 nm) was adjusted to 0.1
with fresh supplemented BHI medium using a spectro-
photometer (1420 Multilabel Counter, Wallac, Perk-
inElmer, Schwerzenbach, Switzerland). This OD590 nm
corresponds approximately to a 0.5 McFarland standard
(National Committee for Clinical Laboratory Standards,
1991). Before each test, a working solution of reuterin
(300 mM, in supplemented BHI) was prepared from the
stock solution (10 M). One hundred microliter of the
working reuterin solution was added in the first row of a
96-well microtiter plates (tissue culture plate, flat bottom,
Greiner Bio-one, St-Gallen, Switzerland) containing 100
μl of supplemented BHI broth and a serial two-fold dilu-
tion was done. Reuterin was not added to the last well of
a column which was used as positive growth control. Each
well was then inoculated with 25 μl of the OD-standard-
ized bacterial suspension. The microtiter plates were incu-
bated in anaerobic jars with an atmosphere generation
system (Oxoid AnaeroGenTM, Oxoid, Bâle, Switzerland)
at 37°C under static conditions until the positive growth
control (tested bacteria grown without reuterin) showed
clear bacterial growth (OD590 nm ≥ 0.8). After incubation,
the OD590 nm was measured using a microtiterplate reader.
Non-inoculated supplemented BHI broth with added
inhibitor, incubated under the same conditions, was used
as a blank. E. coli K12 was used as indicator organism due
to its high sensitivity to reuterin [11]. The MIC was calcu-
lated from the highest dilution showing a complete inhi-
bition of the tested strain (OD590 nm equal to the OD590 nm
of the blank). The MBC, corresponding to the concentra-
tion that killed 99.9 % of the initial inoculum [47], was
determined by spotting 20 μl from a dilution row done
with the samples from first wells showing no visible
growth on supplemented BHI-agar. The MBC was defined
as the lowest concentration at which no growth on the
agar plate was observed [47]. Agar plates were incubated
anaerobically for 48 h in jars. The MBC of reuterin was
expressed in mM. Each organism was tested between 3 to
15 times independently, and the results are expressed as
ranges of MIC or MBC expressed in mM.Page 7 of 9
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The intracellular content of LMW-SH-groups was deter-
mined in deproteinized cell-free extracts of bacterial cul-
tures by the colorimetric method of Ellmann [48], with
some modifications. Bacteria were inoculated at 1% (v/v)
in supplemented BHI and incubated overnight in sealed
bottles under gas atmosphere of N2 and CO2 (1.5 bar,
80:20 [v/v]) at 37°C. Bacterial cell counts were deter-
mined by plating on supplemented BHI agar. Fifteen ml
of the bacterial cultures were centrifuged at 3000 × g for 10
min and pellets were carefully resuspended in 300 μl of B-
PER™ solution. A volume of 130 μl of this solution was
mixed with 130 μl of 5-SSA (2.5 % w/v). The mixture was
incubated for 15 min at 4°C and the precipitated proteins
were removed by centrifugation (10000 × g for 15 min at
4°C). A 150 μl volume of the resulting supernatant was
mixed with 840 μl of potassium buffer (0.2 M, pH 7.5)
and 10 μl of Ellmann's reagent, and incubated 10 min at
room temperature. The absorption was measured at 412
nm (Uvikon 922, Kontron Instrument, Milan, Italy). The
concentration was expressed as μmoles LMW-SH-groups
per 1012 total bacterial cells. A standard curve was done
with various concentrations (0, 20, 40, 60, 80 μM) of glu-
tathione in potassium phosphate buffer (0.2 M, pH 7.5)
that were added to a 75 μl/ml B-PER™ solution (Bacterial
Protein Extraction Reagent, Pierce Chemical Company,
Rockford, Illinois, USA) and the same amount of 5-sul-
fosalicylcylic acid-dihydrate (2.5 % w/v, 5-SSA) for GSH
determination, giving a final volume of 1 ml. After mixing
carefully, 10 μl of Ellmann's reagent (100.9 mM 5,5'-
dithio-bis(2-nitrobenzoic acid) (DTNB) in dimethyl sul-
foxide) was added and the mixture was incubated 10 min
at room temperature. The absorption was measured at
412 nm. Reported data are means of triplicate analyses.
Tolerance to hydrogen peroxide
Cell survival to hydrogen peroxide was determined as pre-
viously described by Doleyres et al. [49] with some modi-
fications. Briefly, 100 μl of an overnight culture of the
tested bacteria was added to 900 μl of H2O2 solution at
different final concentrations (0, 10, 20 or 30 g l-1), and
incubated for 1 min at 37°C. After incubation, 10 μl of
tested sample was added to 490 μl of a catalase solution
(168640 U/ml) to stop the reaction. Cell survival was
determined by plating the appropriate dilution on supple-
mented BHI-agar and incubating 48 h at 37°C. All the
manipulations were done in an anaerobic chamber (Coy
Laboratories, Ann Arbor, MI, USA) under an atmosphere
of nitrogen containing 5 % (v/v) hydrogen. Reported data
and standard deviation are calculated from triplicate anal-
yses.
Statistics
Data for the survival test to hydrogen peroxide did not
meet assumptions of ANOVA (normally distributed and
independent residuals) and were therefore transformed
before analysis.
Values for survival rates after treatments with 10 and 30 g
l-1H2O2 were transformed by log10 function after adding 1.
Values for survival rates after treatment with 20 g l-1 H2O2
were divided by 10 and transformed by log10 function.
Treatment means were compared using the Tukey's test
with the probability level of P < 0.05. The Pearson's corre-
lation was calculated between reuterin activity, tolerance
to H2O2, and LMW-SH concentrations in bacterial cells
using SPSS 13.0 for Windows (SPSS Inc., Chicago, IL,
USA).
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